Ascendis Pharma A/S - Ordinary Share (NQ:ASND)

264.92 +1.41 (+0.54%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 14, 2026 Add to My Watchlist

Price and Volume

Volume	415,492
Open	265.00
Bid (Size)	264.92 (1,700)
Ask (Size)	265.16 (100)
Prev. Close	263.51
Today's Range	260.00 - 265.50
52wk Range	186.05 - 282.15
Shares Outstanding	57,152,295
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Ascendis Pharma (NASDAQ:ASND): Strong Growth Meets a High-Quality Technical Setup ↗

Today 7:10 EDT

Via Chartmill

Ascendis Pharma (NASDAQ:ASND): A Fitting Candidate for Affordable Growth Investors ↗

September 09, 2026

Via Chartmill

Performance

YTD	+24.2%	+24.2%
1 Month	+6.6%	+6.6%
3 Month	+18.6%	+18.6%
6 Month	+14.7%	+14.7%
1 Year	+36.1%	+36.1%

More News

Ascendis Pharma (NASDAQ:ASND) Passes Minervini Trend Template and High Growth Momentum Screen ↗

September 01, 2026

Via Chartmill

If You Invested $1000 In Ascendis Pharma Stock 10 Years Ago, You Would Have This Much Today ↗

August 26, 2026

Via Benzinga

Ascendis Pharma (ASND) Q2 2026 Earnings Call Transcript ↗

August 20, 2026

Via The Motley Fool

Ascendis Pharma (NASDAQ:ASND) Combines High Growth Momentum with a Breakout Setup ↗

August 11, 2026

Via Chartmill

Ascendis Pharma (ASND) Shows High Growth Momentum With Bull Flag Breakout Setup ↗

July 20, 2026

Via Chartmill

ASCENDIS PHARMA A/S (NASDAQ:ASND) Screens as a High-Growth Momentum Candidate ↗

May 18, 2026

Via Chartmill

Ascendis Pharma (NASDAQ:ASND) Shares Drop After Q4 Earnings Miss on Wider-Than-Expected Loss ↗

February 11, 2026

Via Chartmill

Eyconis Announces Initiation of First-in-Human Clinical Trial of EYC-0305 in Treatment-Naïve Wet Age-Related Macular Degeneration Patients

August 18, 2026

From Eyconis Inc.

Via GlobeNewswire

Ascendis Pharma A/S Q2 Earnings Call Highlights ↗

August 13, 2026

Via MarketBeat

Here's How Much $100 Invested In Ascendis Pharma 5 Years Ago Would Be Worth Today ↗

August 11, 2026

Via Benzinga

What to Know About This Fund’s $50 Million Exit From Ascendis Pharma ↗

May 14, 2026

Via The Motley Fool

ASCENDIS PHARMA A/S - ADR (NASDAQ:ASND) Combines Minervini Trend Template with High Growth Momentum ↗

January 28, 2026

Via Chartmill

Energy Fund Yielding 7% and Up 14% in a Year Still Wasn’t Enough to Stop This $3 Million Exit ↗

May 09, 2026

Via The Motley Fool

Ascendis (ASND) Q1 2026 Earnings Call Transcript ↗

May 08, 2026

Via The Motley Fool

Ascendis Pharma Completes Strategic Trifecta with U.S. Launch of YUVIWEL and Seven-Year Orphan Exclusivity

April 13, 2026

Via MarketMinute

Agriculture Stock Up 53% Draws $12 Million Bet. Here's What Long-Term Investors Should Know ↗

March 20, 2026

Via The Motley Fool

Ascendis (ASND) Q4 2025 Earnings Call Transcript ↗

February 23, 2026

Via The Motley Fool

Praxis Stock Surges 320% as One Biotech Investor's Buy Pushes Stake to Nearly $600 Million ↗

February 22, 2026

Via The Motley Fool

Celcuity Stock Soars 700% in a Year as One Investor's $17 Million Buy Helps Create Top Two Position ↗

February 22, 2026

Via The Motley Fool

Apogee Shares Up Nearly 100% in 12 Months, and This $62 Million Buy Signals Ongoing Conviction ↗

February 22, 2026

Via The Motley Fool

$80 Million Arcellx Sale Follows Steep Stock Drop as Rival Drug Emerges ↗

February 22, 2026

Via The Motley Fool

Ascendis Pharma (ASND) Q4 2025 Earnings Transcript ↗

February 11, 2026

Via The Motley Fool

Ascendis Pharma (NASDAQ:ASND) Passes Minervini's Trend Template and High Growth Momentum Scan ↗

December 25, 2025

Via Chartmill

Frequently Asked Questions

Is Ascendis Pharma A/S - Ordinary Share publicly traded?

Yes, Ascendis Pharma A/S - Ordinary Share is publicly traded.

What exchange does Ascendis Pharma A/S - Ordinary Share trade on?

Ascendis Pharma A/S - Ordinary Share trades on the Nasdaq Stock Market

What is the ticker symbol for Ascendis Pharma A/S - Ordinary Share?

The ticker symbol for Ascendis Pharma A/S - Ordinary Share is ASND on the Nasdaq Stock Market

What is the current price of Ascendis Pharma A/S - Ordinary Share?

The current price of Ascendis Pharma A/S - Ordinary Share is 264.92

When was Ascendis Pharma A/S - Ordinary Share last traded?

The last trade of Ascendis Pharma A/S - Ordinary Share was at 09/14/26 04:00 PM ET

What is the market capitalization of Ascendis Pharma A/S - Ordinary Share?

The market capitalization of Ascendis Pharma A/S - Ordinary Share is 15.14B

How many shares of Ascendis Pharma A/S - Ordinary Share are outstanding?

Ascendis Pharma A/S - Ordinary Share has 15B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.